Cullinan Therapeutics Inc

The current institutional shareholding score of Cullinan Therapeutics Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 106.02%, representing a quarter-over-quarter decrease of 19.74%. The largest institutional shareholder is Steven Cohen, holding a total of 829.25K shares, representing 1.47% of shares outstanding, with 0.22% decrease in holdings.